Suchergebnisse - "Patti, Francesco"

PubPharm (14)

1

COVID-19 outbreak in Italy : an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients

enthalten in: Journal of neurology | 2024

von Bisecco, A. | Matrone, F. | Capobianco, M. | +59

2

Ocrelizumab Extended Interval Dosing in Primary Progressive Multiple Sclerosis : An Italian Experience

enthalten in: Current neuropharmacology | 2024

von Zanghì, A. | Ferraro, D. | Callari, G. | +8

3

Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis : a Multicenter, Retrospective, Real-world Study (OPPORTUNITY)

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2023

von Chisari, C. | Bianco, A. | Brescia Morra, V. | +24

4

Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar

enthalten in: Multiple sclerosis and related disorders | 2022

von Yamamura, T. | Weinshenker, B. | Yeaman, M. | +7

CommentIn: Nat Rev Neurol. 2022 Sep;18(9):510. - PMID 35941197

5

Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab : subgroup analysis of REGAIN and its extension study

enthalten in: Muscle & nerve | 2021

von Siddiqi, Z. | Nowak, R. | Mozaffar, T. | +104

6

Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab : A prospective case-control study

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2021

von D'Amico, E. | Zanghì, A. | Calogero, A. | +1

7

DMTs and Covid-19 severity in MS : a pooled analysis from Italy and France

enthalten in: Annals of clinical and translational neurology | 2021

von Sormani, M. | Salvetti, M. | Labauge, P. | +130

8

Long-Term Safety and Efficacy of Eculizumab in Aquaporin-4 IgG-Positive NMOSD

enthalten in: Annals of neurology | 2021

von Wingerchuk, D. | Fujihara, K. | Palace, J. | +112

CommentIn: Ann Neurol. 2021 Jun;89(6):1084-1087. - PMID 33871885

9

Exit Strategies in Natalizumab-Treated RRMS at High Risk of Progressive Multifocal Leukoencephalopathy : a Multicentre Comparison Study

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2021

von Zanghì, A. | Gallo, A. | Avolio, C. | +21

10

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab : an expert consensus

enthalten in: Journal of neurology | 2021

von Filippi, M. | Capra, R. | Centonze, D. | +7